Publisher
Springer International Publishing
Reference12 articles.
1. Agnati LF, Fuxe K. On the mechanism of the antiparkinsonian action of L-DOPA and bromocriptine. J Neural Transm Suppl. 1980;16:69–81.
2. Berde B, Schild HO. Ergot alkaloids and related compounds. Berlin: Springer; 1978.
3. Calne DB, Teychenne PF, Claveria LE, Eastman R, Greenacre JK, Petri A. Bromocriptine in Parkinsonism. Br Med J. 1974;5942:442–4.
4. Chiodini P, Liuzzi A, Cozzi R, Verde G, Oppizzi G, Dallabonza D, Spelta B, Silvestrini F, Borghi G, Tonon C, Horowski R. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. Clin Endocrinol Metab. 1984;53:737–43.
5. Flückiger E, Wagner HR. 2-Br-alpha-kriptine: influence on fertility and lactation. Experientia. 1968;24:1130–1.